Taysha Gene Therapies
TSHA
2,27 €
Share price
-1.87%
Change (1 day)
7.12%
Change (1 year)
Taysha Gene Therapies (TSHA) - Total assets
Total assets on the balance sheet as of March 2025 : €0.11 Billion
According to Taysha Gene Therapies's latest financial reports the company's total assets are €0.11 Billion. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Taysha Gene Therapies - Total assets on balance sheet (from 2020 to 2025)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2024-12-31 | €0.15 B | -1.37% |
| 2023-12-31 | €0.15 B | 32.73% |
| 2022-12-31 | €0.11 B | -37.69% |
| 2021-12-31 | €0.18 B | -10.24% |
| 2020-12-31 | €0.21 B | 1571762.56% |
| 2019-12-31 | €0.01 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | €0.21 B | 75.52% | 🇺🇸 USA |